Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × pyrotinib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 9 HER2-positive Breast Cancer 4 Salivary Gland Neoplasms 1 Non-squamous NSCLC 1 Non Small Cell Lung 1 Locally Advanced Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane 1 HER2 Positive Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Invasive 1 Breast Cancer Female 1 Advanced Digestive System Tumor 1 Advanced Breast Cancer 1

Interventions

Cisplatin 22 Paclitaxel 17 pembrolizumab 14 Carboplatin 12 Radiotherapy 11 tislelizumab 9 Drug Therapy 9 Fluorouracil 8 toripalimab 7 Nivolumab 7 Irinotecan 7 Esophagectomy 6 Neoadjuvant Therapy 5 Docetaxel 5 Radiation 4 Oxaliplatin 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 nimotuzumab 3 lenvatinib 3 Taxes 3 Levoleucovorin 3 Leucovorin 3 spartalizumab 2 sintilimab 2 regorafenib 2 nedaplatin 2 durvalumab 2 apatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡